The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ASML HOLDING NV NY REG SHS | DEPOSITORY RECEIPTS | N07059210 | 636,407,061 | 351,282 | SH | SOLE | 351,282 | 0 | 0 | ||
| BLUE OWL CAPITAL INC | COMMON STOCK | 09581B103 | 603,085 | 66,346 | SH | SOLE | 66,346 | 0 | 0 | ||
| BLUE OWL TECHNOLOGY FINANCE | COMMON STOCK | 095924106 | 381,228,519 | 38,861,215 | SH | SOLE | 38,861,215 | 0 | 0 | ||
| BRIDGEBIO ONCOLOGY THERAPEUT | COMMON STOCK | 107924102 | 10,288,729 | 2,509,446 | SH | SOLE | 2,509,446 | 0 | 0 | ||
| BROOKFIELD CORP | COMMON STOCK | 11271J107 | 327,381,778 | 8,979,204 | SH | SOLE | 8,979,204 | 0 | 0 | ||
| EIKON THERAPEUTICS INC | COMMON STOCK | 282564103 | 5,106,453 | 635,131 | SH | SOLE | 635,131 | 0 | 0 | ||
| SPACE EXPLORATION TECHN CL A | COMMON STOCK | 84615Q103 | 933,704,718 | 6,189,218 | SH | SOLE | 6,189,218 | 0 | 0 | ||
| SPDR GOLD MINISHARES TRUST | MUTUAL FUNDS | 98149E303 | 118,230,558 | 1,438,678 | SH | SOLE | 1,438,678 | 0 | 0 | ||
| STATE STREET CORP | COMMON STOCK | 857477103 | 1,723,909,167 | 9,874,043 | SH | SOLE | 9,874,043 | 0 | 0 | ||
| STATE STREET SPDR UC INVESTMEN | MUTUAL FUNDS | 78468R374 | 2,498,426,486 | 49,795,937 | SH | SOLE | 49,795,937 | 0 | 0 | ||
| SURROZEN INC | COMMON STOCK | 86889P208 | 4,286,601 | 133,207 | SH | SOLE | 133,207 | 0 | 0 | ||